Atlas Trials

Efficacy, Safety and Immunological Evaluation of Upadacitinib for Relapsing Polychondritis

Clinical trial NCT06873100 · RECRUITING

Trial details

NCT number
NCT06873100
Sponsor
Peking University People's Hospital
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Relapsing Polychondritis
Start date
2024-11-15
Primary completion
2026-08-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.